Pmv Pharmaceuticals Inc Cash Flow-to-Debt Ratio
Pmv Pharmaceuticals Inc cash flow-to-debt ratio. Pmv Pharmaceuticals Inc (PMVP) has a Cash Flow-to-Debt Ratio of -1.38x as of June 2026, meaning its operating cash flow of $-14.58 Million could theoretically repay -1% of its total liabilities ($10.57 Million) in one year. See Pmv Pharmaceuticals Inc leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Pmv Pharmaceuticals Inc (2018–2025)
Cash flow-to-debt ratio of Pmv Pharmaceuticals Inc from 2018 to 2025. Historical debt coverage capacity for Pmv Pharmaceuticals Inc across 8 annual periods. Also explore Pmv Pharmaceuticals Inc equity growth rate to track the company's year-over-year net asset growth rate.
Pmv Pharmaceuticals Inc Cash Flow-to-Debt Ratio by Year (2018–2025)
Pmv Pharmaceuticals Inc cash flow-to-debt ratio by year from 2018 to 2025. Year-by-year debt coverage analysis for Pmv Pharmaceuticals Inc. For the full cash flow conversion analysis, see PMVP cash generation efficiency.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -6.21x | $-73.58 Million | $11.85 Million | ▼ -84.1% |
| 2024 | -3.37x | $-51.28 Million | $15.21 Million | ▼ -60.3% |
| 2023 | -2.10x | $-55.66 Million | $26.46 Million | ▲ +19.9% |
| 2022 | -2.63x | $-63.76 Million | $24.28 Million | ▼ -29.7% |
| 2021 | -2.02x | $-46.57 Million | $23.01 Million | ▲ +60.4% |
| 2020 | -5.11x | $-32.74 Million | $6.41 Million | ▼ -3916.2% |
| 2019 | -0.13x | $-22.07 Million | $173.51 Million | ▲ +8.2% |
| 2018 | -0.14x | $-15.18 Million | $109.60 Million | — |